R
About
René R. Kuijten is a Partner and Head of EQT Life Sciences. He is listed as the responsible advisor for Neuravi, a company that developed an innovative stroke treatment and was acquired by Johnson & Johnson in 2017.
Focus Areas
BioTech, HealthTech, Medical Devices, Diagnostics
Verified Contact & Outreach Agent
Direct Professional Email Pattern
AI Outreach Agent Pitch Writer
Compose an personalized, high-converting outreach message targeting their exact investment interest...